Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc.
Your view on DNA
Overview
What the company does, where it operates, and who runs it.
About Ginkgo Bioworks Holdings, Inc.
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jason Kelly
- Headquarters
- 27 Drydock Avenue, Boston, MA, US
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- Jason Kelly
- Headquarters
- 27 Drydock Avenue, Boston, MA, US
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.